Skip to main content

Table 6 Adverse events in the double-blind study

From: Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness

Adverse eventChloroquine subjects (%)Placebo subjects (%)P value
Total subjects with any event44 (76)39 (67)0.4107
Subjects with a serious adverse event5 (9)2 (3)0.4385
Total adverse events109 (100)105 (100)
Infectious51 (47)42 (40)0.0609
Allergy/immunology5 (5)10 (10)0.2681
Musculoskeletal17 (16)15 (15)0.8357
CNS5 (5)3 (3)
Psychiatric5 (5)6 (6)
Hematologic/neoplasm2 (2)2 (2)
Cardiovascular2 (2)3 (3)
GI3 (3)3 (3)
GU2 (2)2 (2)
Metabolic1 (1)6 (6)
Miscellaneous0 (0)3 (3)
Ocular16 (15)10 (10)0.2654
Ocular details
 Retinal33
 Lens42
 Vision20
 Infectious20
 Glaucoma22
  1. Parentheses denote %
  2. P values determined using contingency tables